Jagattaran Das;Nishan Singh;Sanjay Trehan;Sudhir Kumar Sharma;Gurmeet Kaur Nanda;Sastry V. R. S Thungathurthi;Rajesh Jain
发明人:
Rajesh Jain,Sanjay Trehan,Jagattaran Das,Gurmeet Kaur Nanda,Sastry V. R. S Thungathurthi,Nishan Singh,Sudhir Kumar Sharma
申请号：
US14126268
公开号：
US20140228303A1
申请日:
2012.06.13
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2).
